Showing results (51-60 of 280) with videos related to
Sort By:
Pageof 28
Postepy Biochemii|July 17, 2024
The double-stranded microRNA precursorElisabetta Scarfiello, Julian Eichlinger, Gunter MeisterMethods in Molecular Biology (Clifton, N.J.)|July 1, 2018
Identification of microRNA Precursor-Associated ProteinsThomas Treiber, Nora Treiber, Gunter MeisterThe Lancet. Neurology|January 3, 2016
The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational researchReinhard Hohlfeld, Klaus Dornmair, Edgar Meinl, et al.The Lancet. Neurology|January 3, 2016
The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targetsReinhard Hohlfeld, Klaus Dornmair, Edgar Meinl, et al.Trends in Immunology|August 4, 2018
Shedding of BAFF/APRIL Receptors Controls B CellsEdgar Meinl, Franziska S Thaler, Stefan F LichtenthalerJournal of Molecular Medicine (Berlin, Germany)|May 7, 2010
Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injuryTobias Derfuss, Chris Linington, Reinhard Hohlfeld, et al.Nature Reviews. Neurology|October 10, 2012
B cells and antibodies in multiple sclerosis pathogenesis and therapyMarkus Krumbholz, Tobias Derfuss, Reinhard Hohlfeld, et al.Biological Chemistry|September 22, 2023
Post-transcriptional gene silencing in a dynamic RNP worldSimone Larivera, Julia Neumeier, Gunter MeisterMultiple Sclerosis and Related Disorders|May 8, 2023
Ublituximab: A new FDA-approved anti-CD20 mAb for relapsing forms of multiple sclerosisVinícius Oliveira Boldrini, Simone Mader, Tania Kümpfel, et al.Nucleic Acids Research|December 30, 2021
Reexamining assumptions about miRNA-guided gene silencingAudrius Kilikevicius, Gunter Meister, David R CoreyPageof 28